bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio (NASDAQ: BLUE) ('bluebird'), a pioneer in gene therapies for severe genetic diseases, today announced the completion of its sale to funds managed by global investment firms Carlyle (NASDAQ: CG) and SK Capital Partners, LP ('SK Capital'). With the closing of the transaction, bluebird's common stock has ceased trading and will no longer be publicly listed. Carlyle and SK Capital have provided significant primary capital to support and scale bluebird's commercial delivery of gene therapies for patients with sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy.
David Meek, who became Chief Executive Officer of bluebird at close, said, 'Today marks the beginning of a new era for bluebird as its go-forward financial backing and leadership team will better enable all stakeholders to realize the full potential of our revolutionary therapies. Historically, bluebird has excelled as a scientific innovator and should be very proud of the many achievements it has delivered to patients. Our vision is to further that legacy of scientific excellence while improving the commercial execution of our approved products to rapidly expand access to lifechanging gene therapies.'
'We are excited to back bluebird in partnership with SK Capital. We believe providing bluebird the necessary funding along with the new leadership team will help bluebird realize its full potential,' said Joe Bress, Carlyle Partner and Global Co-Head of Healthcare. Bali Muralidhar, Co-Managing Partner and Chief Investment Officer & COO of Abingworth, Carlyle's life sciences investment franchise, added, 'There is an incredible opportunity to bring bluebird's groundbreaking therapies to more patients in need, and we look forward to advancing bluebird in its mission.'
'SK Capital looks forward to partnering with David and his team as well as Carlyle to scale bluebird's pioneering gene therapies that can make a lifechanging difference for patients around the world,' said Aaron Davenport, Managing Director at SK Capital, adding, 'We believe our deep collective experience in manufacturing and commercializing therapies can help drive the next chapter of bluebird's growth.'
Incoming Team Bolsters Commercial Gene Therapy Experience
The company's momentum is reinforced by a deeply experienced management team, led by CEO David Meek. David brings more than 30 years of leadership in life sciences, including as CEO of Mirati Therapeutics and Ipsen. David is joined by Tom Klima as Chief Commercial & Operating Officer, Debasish Roychowdhury, M.D., as Chief Medical Officer, Wendy DiCicco as Chief Financial Officer, and Ellen Forest as Chief People Officer. Additional details are available at https://www.bluebirdbio.com/about-us/leadership.
From Scientific Breakthroughs to Delivery at Scale
With the transaction now closed, bluebird is prioritizing expanding its manufacturing infrastructure, streamlining the patient journey, supporting treatment centers, and strengthening its payer partnerships. The acquisition provides the strategic and financial backing needed to meet rising demand and drive commercial and operational excellence across the organization.
'bluebird has demonstrated what's possible through effective gene therapy,' David added. 'Now we will build the ecosystem to ensure every patient who needs these therapies can access them.'
About bluebird bio
bluebird bio is a commercial-stage biotherapeutics company focused on developing and delivering gene therapies for severe genetic diseases. With more than a decade of scientific leadership in gene therapy and three FDA-approved therapies for sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy, the company is committed to ensuring access, reliability, and patient-centered care. bluebird is headquartered in Somerville, Massachusetts.
About Carlyle
Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across its business and conducts its operations through three business segments: Global Private Equity, Global Credit and Carlyle AlpInvest. With $453 billion of assets under management as of March 31, 2025, Carlyle's purpose is to invest wisely and create value on behalf of its investors, portfolio companies, and the communities in which we live and invest. Carlyle employs more than 2,300 people in 29 offices across four continents. Further information is available at www.carlyle.com. Follow Carlyle on X @OneCarlyle and LinkedIn at The Carlyle Group.
About SK Capital
SK Capital is a transformational private investment firm with a disciplined focus on the life sciences, specialty materials, and ingredients sectors. The firm seeks to build resilient, sustainable, and growing businesses that create substantial long-term value. SK Capital aims to utilize its industry, operating, and investment experience to identify opportunities to transform businesses into higher performing organizations with improved strategic positioning, growth, and profitability, as well as lower operating risk. SK Capital currently has approximately $10 billion in assets under management as of December 31, 2024. For more information, please visit www.skcapitalpartners.com.
Forward Looking Statement
This press release contains 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. All statements that are not statements of historical facts are, or may be deemed to be, forward-looking statements. Such forward-looking statements are based on historical performance and current expectations and projections about bluebird's future goals, plans and objectives and involve inherent risks, assumptions and uncertainties, including internal or external factors that could delay, divert or change any of them in the next several years, that are difficult to predict, may be beyond bluebird's control and could cause bluebird's future goals, plans and objectives to differ materially from those expressed in, or implied by, the statements. No forward-looking statement can be guaranteed. Forward-looking statements in this press release should be evaluated together with the many risks and uncertainties that affect bluebird bio's business, particularly those identified in the risk factors discussion in bluebird bio's Annual Report on Form 10-K for the year ended December 31, 2024, as updated by its subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings with the SEC. These risks and uncertainties include, but are not limited to: the risk that the efficacy and safety results from bluebird's prior and ongoing clinical trials will not continue or be seen in the commercial context; the risk that there is not sufficient patient demand or payer reimbursement to support continued commercialization of bluebird's products; the risk of insertional oncogenic or other safety events associated with lentiviral vector, drug product, or myeloablation, including the risk of hematologic malignancy; and the risk that bluebird's products will not be successfully commercialized. The forward-looking statements included in this document are made only as of the date of this document and except as otherwise required by applicable law, bluebird bio undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances or otherwise.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Why Oil and Gas Stocks Rallied Today
OPEC+ increased supply in line with expectations, leading to a relief rally in oil prices. In addition, Ukraine's daring attack on Russia's long-range bomber fleet increased fears of a geopolitical incident that could further limit Russian oil supply. 10 stocks we like better than TotalEnergies › Shares of major international oil and oil-related stocks such as TotalEnergies (NYSE: TTE), APA (NASDAQ: APA), and oil tanker company Torm plc (NASDAQ: TRMD) rallied on Monday, with the stocks up 2.6%, 4.4%, and 3.4%, respectively, as of 12:45 p.m. ET. TotalEnergies has made strides to become more diversified into renewables, but it still gets over half its operating income from oil and gas upstream production. APA is primarily an upstream oil and gas explorer. And Torm is an oil and gas tanker company involved in global oil and gas transport. Today, oil and gas prices had a "relief rally," as the past weekend's OPEC+ cartel announcements of supply increases weren't as large as feared. Furthermore, Ukraine's daring strike against Russia's bomber fleet over the weekend could potentially escalate the war with Russia, throwing into question Russia's supply on the markets once again. Over the weekend, the OPEC+ cartel announced it would increase oil supply for the month of July by 411,000 barrels per day, an amount in line with expectations. Going into the weekend, some had feared OPEC+ would announce a larger increase. The OPEC+ countries had agreed to voluntary cuts in the neighborhood of 2.2 million barrels per day in January 2024 in order to support oil prices amid stalling growth and growing U.S. production. But in April, the cartel announced it would phase out those voluntary cuts, despite oil prices having fallen this year. While some had feared a bigger surge of production more quickly, it appears the cartel will be phasing in those supply increases more gradually. Additionally, oil prices can surge higher whenever there are geopolitical tensions in oil-producing states. In today's case, it's Russia. We all remember the big surge in oil prices back in 2022, in the aftermath of Russia's invasion of Ukraine. While oil prices have come down this year on the back of tariff-related fears, and perhaps the Trump administration's more Russia-friendly stance leading to sanction relief, Ukraine's daring strike on Russia's long-range bomber fleet this past weekend has raised the prospect of a bigger Russian response. If Russia responds in a big way, it runs the risk of encountering even more sanctions, both on itself and other countries that buy oil from Russia. Russia is the third-largest producer of oil, supplying about 12% of global oil supply. So with that supply now somewhat in question after the past weekend's attack, that's also contributing to the oil price rise. It might seem odd that OPEC+ is increasing production, even though the price of oil has declined in the new year amid the prospect of a macroeconomic slowdown caused by the Trump administration's tariff war. There are potentially several reasons for this. First, some OPEC+ countries were cheating on their quotas anyway, so this is Saudi Arabia's way of punishing them. Second, Saudi Arabia might be trying to curry favor with the Trump administration, which wants lower oil prices and inflation. Third, Saudi Arabia may be moving to a price war strategy to force lower production in U.S. shale, given that Saudi Arabia has the lowest costs per barrel in the world. We actually saw this in the early days of the pandemic, when Saudi Arabia increased oil production even though the world was going into lockdowns, in an effort to bankrupt U.S. shale companies. While today's situation isn't as dire as that, the pivot to competing on price is still not a welcome development for most oil companies. Therefore, today's price increase might end up fleeting, as more production comes online and tariff uncertainty weighs on economic activity. That being said, oil and gas stocks could serve as a valuable hedge against a broader Russia-Ukraine war or increased geopolitical turmoil. So they serve as a valuable component of a diversified portfolio in that respect. Moreover, many oil and gas stocks also pay hefty dividends along the way, while also functioning as a portfolio hedge against that scenario. Before you buy stock in TotalEnergies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and TotalEnergies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $651,049!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $828,224!* Now, it's worth noting Stock Advisor's total average return is 979% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Billy Duberstein and/or his clients have positions in TotalEnergies. The Motley Fool has positions in and recommends Apa. The Motley Fool has a disclosure policy. Why Oil and Gas Stocks Rallied Today was originally published by The Motley Fool
Yahoo
an hour ago
- Yahoo
Where Will Costco Wholesale Stock Be in 5 Years?
Costco Wholesale is a fantastic business that continues to grow. Investors have steadily pushed its valuation higher since the pandemic years. What goes up may ultimately come down -- a seemingly unthinkable outcome for such a winning stock. 10 stocks we like better than Costco Wholesale › Maybe it's those famous $1.50 hot dog meals, but Costco Wholesale (NASDAQ: COST) continues to flex its muscles. The leading membership warehouse retailer reported impressive numbers in its most recent earnings report, highlighting the company's robust customer base at a time when consumers are pulling back at many other stores. The stock's long-term performance is legendary. Costco's shares have risen by over 600% in the past decade alone. The company was a favorite of the late Charlie Munger, who, alongside Warren Buffett, helped run Berkshire Hathaway for decades. I crunched the numbers to see whether the stock's future is as bright as its past. Here is where I think Costco Wholesale stock will be in five years. Costco Wholesale is a warehouse store, which sells items in bulk and other products not typically found at discount retailers, such as Walmart or Target. And people need a paid membership to shop there. The beauty of Costco's business model is that it sells its merchandise at razor-thin margins, while generating most of its profits from membership fees. Its secret sauce, though, is the brand power it has built. Costco has made its stores destinations for consumers, who sometimes go out of their way to visit their closest one for perks like discounted gas or the company's famous $1.50 hot dog meal. The branding works so well that it doesn't spend any money on marketing, an incredible fact, considering how competitive the retail space is. Chatter has picked up this year about a slowing economy, and some companies have sounded the alarm on consumer spending. Yet Costco's most recent quarter featured an impressive 8% increase in net sales (a 5.8% increase in comparable-store traffic) from the same period a year ago. Paid memberships, Costco's core earnings engine, rose by 6.8%. Costco Wholesale is genuinely a world-class business, so it makes total sense that the stock has performed so well over time. But when a stock price rises faster than the company's earnings grow, the valuation goes up. The stock traded at a price-to-earnings (P/E) ratio between 25 and 35 for several years leading up to the COVID-19 pandemic. But over the past five years, that has steadily risen to nearly 60 times earnings today. The stock's P/E ratio is now higher than it was immediately following the pandemic, when stimulus checks temporarily boosted consumer spending and growth expectations. Currently, analysts expect Costco to grow its earnings by 9% to 10% annually over the long term. Paying such a high valuation for just 9% to 10% annualized growth is probably not sustainable. It sets expectations so high that the stock could abruptly crumble at the first sign of trouble, or the stock could plateau until Costco's earnings grow and catch up to the valuation. I looked five years ahead to see what that might look like. Costco Wholesale has one quarter left in its fiscal 2025. Analysts believe its full-year earnings will come in around $18 per share. Suppose the company grows earnings at a 10% annualized rate from there. That's higher than what analysts currently estimate, but I'm trying to be generous to make a point. Doing the math, Costco's growth in earnings per share would look like: Fiscal year 2026: $19.80 Fiscal year 2027: $21.78 Fiscal year 2028: $23.96 Fiscal year 2029: $26.35 Fiscal year 2030: $28.99 By then, the stock price will depend on what the market values Costco Wholesale at. The stock routinely traded at a P/E of around 30 before the pandemic. If you apply that to Costco's hypothetical 2030 earnings, you'd get a share price of $870. Unfortunately, Costco Wholesale traded at $1,040 per share at the time of this writing. That's why I think the stock will be lower in five years. As great as the company is, there isn't nearly enough growth to justify such a high valuation, meaning there are potentially years of business growth already reflected in the share price today. Unfortunately, even the best companies can be lousy stocks if you overpay, so consider avoiding Costco until the price drops quite a bit. Before you buy stock in Costco Wholesale, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Costco Wholesale wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $657,385!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $842,015!* Now, it's worth noting Stock Advisor's total average return is 987% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Justin Pope has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Berkshire Hathaway, Costco Wholesale, Target, and Walmart. The Motley Fool has a disclosure policy. Where Will Costco Wholesale Stock Be in 5 Years? was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Performance Shipping Inc. Announces Fixed Income Investor Meetings
ATHENS, Greece, June 04, 2025 (GLOBE NEWSWIRE) -- Performance Shipping Inc. (NASDAQ: PSHG) ('Performance Shipping' or the 'Company'), through its Norwegian investment banks, will arrange a series of fixed income investor calls commencing on June 6, 2025. A five-year USD denominated senior unsecured bond issue may follow, subject to inter alia market conditions. The net proceeds from the contemplated bond issue shall be applied towards fleet expansion and renewal and general corporate purposes of the Company. The senior unsecured bonds, if issued, will be offered in the United States or its territories only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the 'U.S. Securities Act'), and sold outside the United States only to non-U.S. persons pursuant to Regulation S under the Securities Act. The bonds, if issued, will not be registered under the Securities Act or any state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities of Performance Shipping Inc., nor shall it constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful, and is being issued in the United States pursuant to and in accordance with Rule 135c under the Securities Act. About the Company Performance Shipping Inc. is a global provider of shipping transportation services through its ownership of tanker vessels. The Company employs its fleet on spot voyages, through pool arrangements and on time charters. Cautionary Statement Regarding Forward-Looking Statements Matters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include, but are not limited to, statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts, including with respect to the delivery of the vessels we have agreed to acquire, future market conditions and the prospective financing and employment of our vessels. The words 'believe," 'anticipate," 'intends," 'estimate," 'forecast," 'project," 'plan," 'potential," 'will," 'may," 'should," 'expect," 'targets," 'likely," 'would," 'could," 'seeks," 'continue," 'possible," 'might," 'pending' and similar expressions, terms or phrases may identify forward-looking statements. The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including, without limitation, our management's examination of historical operating trends, data contained in our records and other data available from third parties. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations, beliefs, or projections. In addition to these important factors, other important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include, but are not limited to: the strength of world economies, fluctuations in currencies and interest rates, general market conditions, including fluctuations in charter rates and vessel values, changes in demand in the tanker shipping industry, changes in the supply of vessels, changes in worldwide oil production and consumption and storage, changes in our operating expenses, including bunker prices, crew costs, drydocking and insurance costs, our future operating or financial results, availability of financing and refinancing including with respect to vessels we agree to acquire, changes in governmental rules and regulations or actions taken by regulatory authorities, potential liability from pending or future litigation, general domestic and international political conditions, the length and severity of epidemics and pandemics, including COVID-19, and their impact on the demand for seaborne transportation of petroleum and other types of products, changes in governmental rules and regulations or actions taken by regulatory authorities, general domestic and international political conditions or events, including 'trade wars', armed conflicts including the war in Ukraine and the war between Israel and Hamas or Iran, the imposition of new international sanctions, acts by terrorists or acts of piracy on ocean-going vessels, potential disruption of shipping routes due to accidents, labor disputes or political events, vessel breakdowns and instances of off-hires and other important factors. Please see our filings with the US Securities and Exchange Commission for a more complete discussion of these and other risks and uncertainties. CONTACT: Corporate Contact: Andreas Michalopoulos Chief Executive Officer, Director and Secretary Telephone: +30-216-600-2400 Email: amichalopoulos@ Website: Investor and Media Relations: Edward Nebb Comm-Counsellors, LLC Telephone: + 1-203-972-8350 Email: enebb@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
